跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 49,532 条关于
“KKR & Co. Inc.”
全部
49,532
临床试验
13,899
药物
2,706
机构
7,634
资讯
25,293
6个月前
Heidelberg Pharma Secures $45 Million Through Modified Licensing Agreement with HealthCare Royalty and Soleus Capital
10个月前
Nanobiotix Secures $71 Million Royalty Financing to Advance Cancer Nanotherapy Through 2028
14天前
KKR to Sell Minority Stake in Nordic Bioscience to Founder Claus Christiansen
去年
KKR and Ajax Health Launch FlowMod to Develop Novel Heart Failure Treatment Platform
去年
KEYNOTE-057 Trial Explores Vibostolimab and Favezelimab Combinations with Pembrolizumab in BCG-Unresponsive NMIBC
2年前
Bambusa Therapeutics Secures $15 Million Seed Funding for Bispecific Antibody Development
去年
Torrent Pharma Advances $2.4 Billion Acquisition of JB Chemicals in Major Industry Consolidation Move
去年
Novo Holdings Makes Landmark Investment in Fungal Biotech Leader Sylvan to Accelerate Sustainable Solutions
去年
FDA Approves Verquvo (vericiguat) for Chronic Heart Failure with Reduced Ejection Fraction
7个月前
Hyaluronidase Co-Administration Enhances Cancer Immunotherapy Efficacy Through Subcutaneous Delivery
第 1 页,共 2530 页
上一页
下一页